Hoth Therapeutics Inc

General ticker "HOTH" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $5.7M

Hoth Therapeutics Inc does not follow the US Stock Market performance with the rate: -34.7%.

Estimated limits based on current volatility of 3.9%: low 0.77$, high 0.83$

Factors to consider:

  • Current price 17.9% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.00$, 3.09$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.21$, 3.38$]

Financial Metrics affecting the HOTH estimates:

  • Negative: Non-GAAP EPS, $ of -2.37 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -67.01 <= 2.35
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39

Similar symbols

Short-term HOTH quotes

Long-term HOTH plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $14.10MM $11.07MM $7.69MM
Operating Income $-14.10MM $-11.07MM $-7.69MM
Non-Operating Income $-0.25MM $-0.31MM $-0.15MM
Interest Expense $0.00MM $0.31MM $0.00MM
R&D Expense $7.53MM $4.93MM $3.48MM
Income(Loss) $-14.35MM $-11.38MM $-7.85MM
Profit(Loss) $-14.35MM $-11.38MM $-7.85MM
Stockholders Equity $9.88MM $5.12MM $8.82MM
Assets $10.99MM $6.76MM $9.52MM
Operating Cash Flow $-12.09MM $-9.30MM $-8.45MM
Capital expenditure $0.12MM $0.07MM $0.00MM
Investing Cash Flow $-0.17MM $1.16MM $0.00MM
Financing Cash Flow $18.19MM $6.04MM $11.32MM
Earnings Per Share* $-16.03 $-9.75 $-2.30

* EPS are Split Adjusted, recent splits may be reflected with a delay.